ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Remdesivir (COVID-19) Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-3X8392
Home | Market Reports | Health| Pharmacy
Global and United States Remdesivir COVID 19 Market Insights Forecast to 2027
BUY CHAPTERS

Global Remdesivir (COVID-19) Market Research Report 2025

Code: QYRE-Auto-3X8392
Report
July 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Gilead Sciences
Bright Gene
Hainan Haiyao
Kelun Pharma
Hunan Warrant Pharmaceutical
Borui Bio-Pharmaceutical
Berry Global Group
Inovio Pharmaceuticals

Remdesivir (COVID-19) Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Remdesivir (COVID-19) Market

Remdesivir (COVID-19) Market

The global market for Remdesivir (COVID-19) was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Remdesivir (COVID-19), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Remdesivir (COVID-19).
The Remdesivir (COVID-19) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Remdesivir (COVID-19) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Remdesivir (COVID-19) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Remdesivir (COVID-19) Market Report

Report Metric Details
Report Name Remdesivir (COVID-19) Market
CAGR 5%
Segment by Type
  • 5mg
  • 10mg
  • 50mg
  • 100mg
Segment by Application
  • Hospital
  • Clinics
  • Drug Store
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Gilead Sciences, Bright Gene, Hainan Haiyao, Kelun Pharma, Hunan Warrant Pharmaceutical, Borui Bio-Pharmaceutical, Berry Global Group, Inovio Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Remdesivir (COVID-19) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Remdesivir (COVID-19) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Remdesivir (COVID-19) Market report?

Ans: The main players in the Remdesivir (COVID-19) Market are Gilead Sciences, Bright Gene, Hainan Haiyao, Kelun Pharma, Hunan Warrant Pharmaceutical, Borui Bio-Pharmaceutical, Berry Global Group, Inovio Pharmaceuticals

What are the Application segmentation covered in the Remdesivir (COVID-19) Market report?

Ans: The Applications covered in the Remdesivir (COVID-19) Market report are Hospital, Clinics, Drug Store, Others

What are the Type segmentation covered in the Remdesivir (COVID-19) Market report?

Ans: The Types covered in the Remdesivir (COVID-19) Market report are 5mg, 10mg, 50mg, 100mg

Recommended Reports

Antiviral And Covid

COVID-19 Diagnostics

Therapies And Vaccines

1 Remdesivir (COVID-19) Market Overview
1.1 Product Definition
1.2 Remdesivir (COVID-19) by Type
1.2.1 Global Remdesivir (COVID-19) Market Value Comparison by Type (2024 VS 2031)
1.2.2 5mg
1.2.3 10mg
1.2.4 50mg
1.2.5 100mg
1.3 Remdesivir (COVID-19) by Application
1.3.1 Global Remdesivir (COVID-19) Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Drug Store
1.3.5 Others
1.4 Global Remdesivir (COVID-19) Market Size Estimates and Forecasts
1.4.1 Global Remdesivir (COVID-19) Revenue 2020-2031
1.4.2 Global Remdesivir (COVID-19) Sales 2020-2031
1.4.3 Global Remdesivir (COVID-19) Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Remdesivir (COVID-19) Market Competition by Manufacturers
2.1 Global Remdesivir (COVID-19) Sales Market Share by Manufacturers (2020-2025)
2.2 Global Remdesivir (COVID-19) Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Remdesivir (COVID-19) Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Remdesivir (COVID-19), Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Remdesivir (COVID-19), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Remdesivir (COVID-19), Product Type & Application
2.7 Global Key Manufacturers of Remdesivir (COVID-19), Date of Enter into This Industry
2.8 Global Remdesivir (COVID-19) Market Competitive Situation and Trends
2.8.1 Global Remdesivir (COVID-19) Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Remdesivir (COVID-19) Players Market Share by Revenue
2.8.3 Global Remdesivir (COVID-19) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Remdesivir (COVID-19) Market Scenario by Region
3.1 Global Remdesivir (COVID-19) Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Remdesivir (COVID-19) Sales by Region: 2020-2031
3.2.1 Global Remdesivir (COVID-19) Sales by Region: 2020-2025
3.2.2 Global Remdesivir (COVID-19) Sales by Region: 2026-2031
3.3 Global Remdesivir (COVID-19) Revenue by Region: 2020-2031
3.3.1 Global Remdesivir (COVID-19) Revenue by Region: 2020-2025
3.3.2 Global Remdesivir (COVID-19) Revenue by Region: 2026-2031
3.4 North America Remdesivir (COVID-19) Market Facts & Figures by Country
3.4.1 North America Remdesivir (COVID-19) Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Remdesivir (COVID-19) Sales by Country (2020-2031)
3.4.3 North America Remdesivir (COVID-19) Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Remdesivir (COVID-19) Market Facts & Figures by Country
3.5.1 Europe Remdesivir (COVID-19) Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Remdesivir (COVID-19) Sales by Country (2020-2031)
3.5.3 Europe Remdesivir (COVID-19) Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Remdesivir (COVID-19) Market Facts & Figures by Region
3.6.1 Asia Pacific Remdesivir (COVID-19) Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Remdesivir (COVID-19) Sales by Region (2020-2031)
3.6.3 Asia Pacific Remdesivir (COVID-19) Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Remdesivir (COVID-19) Market Facts & Figures by Country
3.7.1 Latin America Remdesivir (COVID-19) Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Remdesivir (COVID-19) Sales by Country (2020-2031)
3.7.3 Latin America Remdesivir (COVID-19) Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Remdesivir (COVID-19) Market Facts & Figures by Country
3.8.1 Middle East and Africa Remdesivir (COVID-19) Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Remdesivir (COVID-19) Sales by Country (2020-2031)
3.8.3 Middle East and Africa Remdesivir (COVID-19) Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Remdesivir (COVID-19) Sales by Type (2020-2031)
4.1.1 Global Remdesivir (COVID-19) Sales by Type (2020-2025)
4.1.2 Global Remdesivir (COVID-19) Sales by Type (2026-2031)
4.1.3 Global Remdesivir (COVID-19) Sales Market Share by Type (2020-2031)
4.2 Global Remdesivir (COVID-19) Revenue by Type (2020-2031)
4.2.1 Global Remdesivir (COVID-19) Revenue by Type (2020-2025)
4.2.2 Global Remdesivir (COVID-19) Revenue by Type (2026-2031)
4.2.3 Global Remdesivir (COVID-19) Revenue Market Share by Type (2020-2031)
4.3 Global Remdesivir (COVID-19) Price by Type (2020-2031)
5 Segment by Application
5.1 Global Remdesivir (COVID-19) Sales by Application (2020-2031)
5.1.1 Global Remdesivir (COVID-19) Sales by Application (2020-2025)
5.1.2 Global Remdesivir (COVID-19) Sales by Application (2026-2031)
5.1.3 Global Remdesivir (COVID-19) Sales Market Share by Application (2020-2031)
5.2 Global Remdesivir (COVID-19) Revenue by Application (2020-2031)
5.2.1 Global Remdesivir (COVID-19) Revenue by Application (2020-2025)
5.2.2 Global Remdesivir (COVID-19) Revenue by Application (2026-2031)
5.2.3 Global Remdesivir (COVID-19) Revenue Market Share by Application (2020-2031)
5.3 Global Remdesivir (COVID-19) Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Gilead Sciences
6.1.1 Gilead Sciences Company Information
6.1.2 Gilead Sciences Description and Business Overview
6.1.3 Gilead Sciences Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Gilead Sciences Remdesivir (COVID-19) Product Portfolio
6.1.5 Gilead Sciences Recent Developments/Updates
6.2 Bright Gene
6.2.1 Bright Gene Company Information
6.2.2 Bright Gene Description and Business Overview
6.2.3 Bright Gene Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Bright Gene Remdesivir (COVID-19) Product Portfolio
6.2.5 Bright Gene Recent Developments/Updates
6.3 Hainan Haiyao
6.3.1 Hainan Haiyao Company Information
6.3.2 Hainan Haiyao Description and Business Overview
6.3.3 Hainan Haiyao Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hainan Haiyao Remdesivir (COVID-19) Product Portfolio
6.3.5 Hainan Haiyao Recent Developments/Updates
6.4 Kelun Pharma
6.4.1 Kelun Pharma Company Information
6.4.2 Kelun Pharma Description and Business Overview
6.4.3 Kelun Pharma Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Kelun Pharma Remdesivir (COVID-19) Product Portfolio
6.4.5 Kelun Pharma Recent Developments/Updates
6.5 Hunan Warrant Pharmaceutical
6.5.1 Hunan Warrant Pharmaceutical Company Information
6.5.2 Hunan Warrant Pharmaceutical Description and Business Overview
6.5.3 Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Product Portfolio
6.5.5 Hunan Warrant Pharmaceutical Recent Developments/Updates
6.6 Borui Bio-Pharmaceutical
6.6.1 Borui Bio-Pharmaceutical Company Information
6.6.2 Borui Bio-Pharmaceutical Description and Business Overview
6.6.3 Borui Bio-Pharmaceutical Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Borui Bio-Pharmaceutical Remdesivir (COVID-19) Product Portfolio
6.6.5 Borui Bio-Pharmaceutical Recent Developments/Updates
6.7 Berry Global Group
6.7.1 Berry Global Group Company Information
6.7.2 Berry Global Group Description and Business Overview
6.7.3 Berry Global Group Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Berry Global Group Remdesivir (COVID-19) Product Portfolio
6.7.5 Berry Global Group Recent Developments/Updates
6.8 Inovio Pharmaceuticals
6.8.1 Inovio Pharmaceuticals Company Information
6.8.2 Inovio Pharmaceuticals Description and Business Overview
6.8.3 Inovio Pharmaceuticals Remdesivir (COVID-19) Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Inovio Pharmaceuticals Remdesivir (COVID-19) Product Portfolio
6.8.5 Inovio Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Remdesivir (COVID-19) Industry Chain Analysis
7.2 Remdesivir (COVID-19) Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Remdesivir (COVID-19) Production Mode & Process Analysis
7.4 Remdesivir (COVID-19) Sales and Marketing
7.4.1 Remdesivir (COVID-19) Sales Channels
7.4.2 Remdesivir (COVID-19) Distributors
7.5 Remdesivir (COVID-19) Customer Analysis
8 Remdesivir (COVID-19) Market Dynamics
8.1 Remdesivir (COVID-19) Industry Trends
8.2 Remdesivir (COVID-19) Market Drivers
8.3 Remdesivir (COVID-19) Market Challenges
8.4 Remdesivir (COVID-19) Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Gilead Sciences
Bright Gene
Hainan Haiyao
Kelun Pharma
Hunan Warrant Pharmaceutical
Borui Bio-Pharmaceutical
Berry Global Group
Inovio Pharmaceuticals
List of Tables
 Table 1. Global Remdesivir (COVID-19) Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Remdesivir (COVID-19) Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Remdesivir (COVID-19) Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Remdesivir (COVID-19) Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Remdesivir (COVID-19) Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Remdesivir (COVID-19) Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Remdesivir (COVID-19) Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Remdesivir (COVID-19) Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Remdesivir (COVID-19), Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Remdesivir (COVID-19), Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Remdesivir (COVID-19), Product Type & Application
 Table 12. Global Key Manufacturers of Remdesivir (COVID-19), Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Remdesivir (COVID-19) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Remdesivir (COVID-19) as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Remdesivir (COVID-19) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Remdesivir (COVID-19) Sales by Region (2020-2025) & (K Units)
 Table 18. Global Remdesivir (COVID-19) Sales Market Share by Region (2020-2025)
 Table 19. Global Remdesivir (COVID-19) Sales by Region (2026-2031) & (K Units)
 Table 20. Global Remdesivir (COVID-19) Sales Market Share by Region (2026-2031)
 Table 21. Global Remdesivir (COVID-19) Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Remdesivir (COVID-19) Revenue Market Share by Region (2020-2025)
 Table 23. Global Remdesivir (COVID-19) Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Remdesivir (COVID-19) Revenue Market Share by Region (2026-2031)
 Table 25. North America Remdesivir (COVID-19) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Remdesivir (COVID-19) Sales by Country (2020-2025) & (K Units)
 Table 27. North America Remdesivir (COVID-19) Sales by Country (2026-2031) & (K Units)
 Table 28. North America Remdesivir (COVID-19) Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Remdesivir (COVID-19) Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Remdesivir (COVID-19) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Remdesivir (COVID-19) Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Remdesivir (COVID-19) Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Remdesivir (COVID-19) Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Remdesivir (COVID-19) Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Remdesivir (COVID-19) Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Remdesivir (COVID-19) Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Remdesivir (COVID-19) Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Remdesivir (COVID-19) Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Remdesivir (COVID-19) Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Remdesivir (COVID-19) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Remdesivir (COVID-19) Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Remdesivir (COVID-19) Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Remdesivir (COVID-19) Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Remdesivir (COVID-19) Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Remdesivir (COVID-19) Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Remdesivir (COVID-19) Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Remdesivir (COVID-19) Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Remdesivir (COVID-19) Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Remdesivir (COVID-19) Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Remdesivir (COVID-19) Sales (K Units) by Type (2020-2025)
 Table 51. Global Remdesivir (COVID-19) Sales (K Units) by Type (2026-2031)
 Table 52. Global Remdesivir (COVID-19) Sales Market Share by Type (2020-2025)
 Table 53. Global Remdesivir (COVID-19) Sales Market Share by Type (2026-2031)
 Table 54. Global Remdesivir (COVID-19) Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Remdesivir (COVID-19) Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Remdesivir (COVID-19) Revenue Market Share by Type (2020-2025)
 Table 57. Global Remdesivir (COVID-19) Revenue Market Share by Type (2026-2031)
 Table 58. Global Remdesivir (COVID-19) Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Remdesivir (COVID-19) Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Remdesivir (COVID-19) Sales (K Units) by Application (2020-2025)
 Table 61. Global Remdesivir (COVID-19) Sales (K Units) by Application (2026-2031)
 Table 62. Global Remdesivir (COVID-19) Sales Market Share by Application (2020-2025)
 Table 63. Global Remdesivir (COVID-19) Sales Market Share by Application (2026-2031)
 Table 64. Global Remdesivir (COVID-19) Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Remdesivir (COVID-19) Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Remdesivir (COVID-19) Revenue Market Share by Application (2020-2025)
 Table 67. Global Remdesivir (COVID-19) Revenue Market Share by Application (2026-2031)
 Table 68. Global Remdesivir (COVID-19) Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Remdesivir (COVID-19) Price (US$/Unit) by Application (2026-2031)
 Table 70. Gilead Sciences Company Information
 Table 71. Gilead Sciences Description and Business Overview
 Table 72. Gilead Sciences Remdesivir (COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Gilead Sciences Remdesivir (COVID-19) Product
 Table 74. Gilead Sciences Recent Developments/Updates
 Table 75. Bright Gene Company Information
 Table 76. Bright Gene Description and Business Overview
 Table 77. Bright Gene Remdesivir (COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Bright Gene Remdesivir (COVID-19) Product
 Table 79. Bright Gene Recent Developments/Updates
 Table 80. Hainan Haiyao Company Information
 Table 81. Hainan Haiyao Description and Business Overview
 Table 82. Hainan Haiyao Remdesivir (COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Hainan Haiyao Remdesivir (COVID-19) Product
 Table 84. Hainan Haiyao Recent Developments/Updates
 Table 85. Kelun Pharma Company Information
 Table 86. Kelun Pharma Description and Business Overview
 Table 87. Kelun Pharma Remdesivir (COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Kelun Pharma Remdesivir (COVID-19) Product
 Table 89. Kelun Pharma Recent Developments/Updates
 Table 90. Hunan Warrant Pharmaceutical Company Information
 Table 91. Hunan Warrant Pharmaceutical Description and Business Overview
 Table 92. Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Hunan Warrant Pharmaceutical Remdesivir (COVID-19) Product
 Table 94. Hunan Warrant Pharmaceutical Recent Developments/Updates
 Table 95. Borui Bio-Pharmaceutical Company Information
 Table 96. Borui Bio-Pharmaceutical Description and Business Overview
 Table 97. Borui Bio-Pharmaceutical Remdesivir (COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Borui Bio-Pharmaceutical Remdesivir (COVID-19) Product
 Table 99. Borui Bio-Pharmaceutical Recent Developments/Updates
 Table 100. Berry Global Group Company Information
 Table 101. Berry Global Group Description and Business Overview
 Table 102. Berry Global Group Remdesivir (COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Berry Global Group Remdesivir (COVID-19) Product
 Table 104. Berry Global Group Recent Developments/Updates
 Table 105. Inovio Pharmaceuticals Company Information
 Table 106. Inovio Pharmaceuticals Description and Business Overview
 Table 107. Inovio Pharmaceuticals Remdesivir (COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Inovio Pharmaceuticals Remdesivir (COVID-19) Product
 Table 109. Inovio Pharmaceuticals Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Remdesivir (COVID-19) Distributors List
 Table 113. Remdesivir (COVID-19) Customers List
 Table 114. Remdesivir (COVID-19) Market Trends
 Table 115. Remdesivir (COVID-19) Market Drivers
 Table 116. Remdesivir (COVID-19) Market Challenges
 Table 117. Remdesivir (COVID-19) Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Remdesivir (COVID-19)
 Figure 2. Global Remdesivir (COVID-19) Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Remdesivir (COVID-19) Market Share by Type: 2024 & 2031
 Figure 4. 5mg Product Picture
 Figure 5. 10mg Product Picture
 Figure 6. 50mg Product Picture
 Figure 7. 100mg Product Picture
 Figure 8. Global Remdesivir (COVID-19) Market Value by Application (2020-2031) & (US$ Million)
 Figure 9. Global Remdesivir (COVID-19) Market Share by Application: 2024 & 2031
 Figure 10. Hospital
 Figure 11. Clinics
 Figure 12. Drug Store
 Figure 13. Others
 Figure 14. Global Remdesivir (COVID-19) Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Remdesivir (COVID-19) Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Remdesivir (COVID-19) Sales (2020-2031) & (K Units)
 Figure 17. Global Remdesivir (COVID-19) Average Price (US$/Unit) & (2020-2031)
 Figure 18. Remdesivir (COVID-19) Report Years Considered
 Figure 19. Remdesivir (COVID-19) Sales Share by Manufacturers in 2024
 Figure 20. Global Remdesivir (COVID-19) Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Remdesivir (COVID-19) Players: Market Share by Revenue in Remdesivir (COVID-19) in 2024
 Figure 22. Remdesivir (COVID-19) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Remdesivir (COVID-19) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Remdesivir (COVID-19) Sales Market Share by Country (2020-2031)
 Figure 25. North America Remdesivir (COVID-19) Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Remdesivir (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Remdesivir (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Remdesivir (COVID-19) Sales Market Share by Country (2020-2031)
 Figure 29. Europe Remdesivir (COVID-19) Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Remdesivir (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Remdesivir (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Remdesivir (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Remdesivir (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Remdesivir (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Remdesivir (COVID-19) Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Remdesivir (COVID-19) Revenue Market Share by Region (2020-2031)
 Figure 37. China Remdesivir (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Remdesivir (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Remdesivir (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Remdesivir (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Remdesivir (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Remdesivir (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Remdesivir (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Remdesivir (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Remdesivir (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Remdesivir (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Remdesivir (COVID-19) Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Remdesivir (COVID-19) Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Remdesivir (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Remdesivir (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Remdesivir (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Remdesivir (COVID-19) Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Remdesivir (COVID-19) Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Remdesivir (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Remdesivir (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. UAE Remdesivir (COVID-19) Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Remdesivir (COVID-19) by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Remdesivir (COVID-19) by Type (2020-2031)
 Figure 59. Global Remdesivir (COVID-19) Price (US$/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Remdesivir (COVID-19) by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Remdesivir (COVID-19) by Application (2020-2031)
 Figure 62. Global Remdesivir (COVID-19) Price (US$/Unit) by Application (2020-2031)
 Figure 63. Remdesivir (COVID-19) Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

COVID 19 Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Covid 19 Therapeutic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global COVID 19 Medicine Market Research Report 2024
Specific Antiviral Drugs for COVID 19 Market
Covid 19 Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
COVID 19 Drug API Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral COVID 19 Antiviral Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Antiviral Medicines for COVID 19 Market Research Report 2024
COVID 19 Diagnostic Tests Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral COVID 19 Drug Market Research Report 2025
COVID 19 DNA Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Covid 19 Diagnostic Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Oral COVID 19 Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Covid 19 Rapid Diagnostic Test Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Covid 19 Vaccine Bottle Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
COVID 19 Test Kits Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antiviral Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
COVID 19 In Vitro Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Approved COVID 19 Vaccines Market Research Report 2025

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions